Show results for
Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Platform Microbiotica Drug Equipment Supplied In Usa
32 equipment items found
Manufactured by:Windgap Medical, Inc. based inWatertown, MASSACHUSETTS (USA)
The ANDIPEN is a wet/dry dual-chamber autoinjector built to drastically improve temperature resilience and shelf lives of medications traditionally offered and stored in liquid form. The ANDI® Platform is the basis for our epinephrine product, currently in pre-production in partnership with ...
Manufactured by:Exparel based inParsippany, NEW JERSEY (USA)
EXPAREL uses proprietary multivesicular liposome (pMVL) technology, an advanced drug delivery platform, to extend analgesia. ...
Manufactured by:Windgap Medical, Inc. based inWatertown, MASSACHUSETTS (USA)
Our thermally stable drug delivery platform will automate rehydration and administration with twice the shelf life and half the size of current anaphylaxis ...
Manufactured by:Insulet Corporation based inActon, MASSACHUSETTS (USA)
OmniPod is a unique, automated drug delivery platform that offers improved adherence, outcomes and differentiation throughout a drug’s ...
by:Ainovo Biotech Inc. based inSacramento, CALIFORNIA (USA)
AlOptimus™ brings to bear AINovo's proprietary machine learning algorithms on our highly curated datasets to enhance the therapeutic profiles of drug candidates. The AlOptimus platform optimizes validated candidates to derisk development and inform clinical ...
by:Alloy Therapeutics, Inc. based inLexington, MASSACHUSETTS (USA)
ATX-Gx™, our first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. There are three ways to access the ATX-Gx™ ...
Manufactured by:Verge Genomics based inSouth San Francisco, CALIFORNIA (USA)
The breadth and depth of our pipeline demonstrates the power of the ConVERGEMplatform. All pipeline programs have been discovered and developed on our proprietary platform. ...
Manufactured by:Windgap Medical, Inc. based inWatertown, MASSACHUSETTS (USA)
This device is supported by an ongoing NIH grant and potential for follow-on ...
Manufactured by:Obsidian Therapeutics, Inc. based inCambridge, MASSACHUSETTS (USA)
Our proprietary cytoDRiVE® platform leverages drug responsive domains (DRDs) to control protein function using an FDA-approved small ...
Manufactured by:Rebiotix Inc., a Ferring Company based inRoseville, MINNESOTA (USA)
Rebiotix Inc., a Ferring Company, has leveraged its clinical, manufacturing and regulatory experience with RBX2660 to develop the first of its kind non-frozen, room temperature stable oral microbiota-based formulation under the MRT™ drug platform, known as RBX7455. While it is currently used to reduce the incidence of recurrent Clostridioides difficile infection, additional indications are ...
Manufactured by:LayerBio, Inc based inBoston, MASSACHUSETTS (USA)
OcuRing is a bioerodible sustained-release implant applied to the haptic of an intraocular lens (IOL) for use in cataract surgery. Once implanted inside the eye, the OcuRing continuously releases medications for treatment and prevention of postoperative complications of cataract ...
Manufactured by:InSphero AG based inSchlieren, SWITZERLAND
When you’re ready, we deliver. InSphero assay-ready spheroid microtissues are engineered and certified for use in critical drug development applications, and validated to ensure uniform size, robust functionality, and reproducible results. We develop 3D InSight™ Microtissues using the most advanced 3D cell culture technologies available to produce highly predictive, fully QC’d ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
with a modular suite of proprietary cytotoxins (cell-killing compounds), stable linkers, and conjugation technologies. A broader window of opportunity. Deliver potent cell-killing compounds specifically to diseased target cells with optimal safety and efficacy. ZymeLink™, a next-generation antibody drug conjugate (ADC) platform, is a suite of proprietary cytotoxins (cell-killing compounds), ...
Manufactured by:Cingulate based inKansas City, KANSAS (USA)
CTx-1302 utilizes a breakthrough multi-core formulation of dextroamphetamine, a compound approved by the FDA for the treatment of ...
Manufactured by:Rebiotix Inc., a Ferring Company based inRoseville, MINNESOTA (USA)
Rebiotix Inc., a Ferring Company, has conducted several trials of the lead microbiota-based product in the MRT drug platform, RBX2660, for reducing the rate of recurrence of Clostridioides difficile infection. RBX2660 is currently under study in a Phase 3 clinical trial in conjunction with the US Food and Drug Administration’s Investigational New Drug ...
Manufactured by:Bexson Biomedical based inSanta Barbara, CALIFORNIA (USA)
Partnering with the Stevanato Group, we are creating the first modular, pre-filled, and pre-sterilized subcutaneous pump that can be utilized to deliver hundreds of ...
Manufactured by:Cingulate based inKansas City, KANSAS (USA)
CTx-1301 utilizes a breakthrough multi-core formulation of dexmethylphenidate, a compound approved by the FDA for the treatment of ...
Manufactured by:Base4 based inChicago, ILLINOIS (USA)
Leading the RNA ensemble revolution. Exploiting RNA dynamics: RNAs rapidly exchange between a vast array of distinct 3D conformations, each revealing potentially novel binding surfaces. These dynamics are critical to understanding RNA function and fully exploiting its untapped drug potential. Our proprietary platform is built on unparalleled advancements in RNA structural biology that allows for ...
Manufactured by:Mediprint Ophthalmics based inSan Diego, CALIFORNIA (USA)
We have proprietary printing technology and ink that allows for the sustained, continuous release of ophthalmic drugs via contact lenses and it is called the MediPrint process. Our unique process results in a novel way to for treat various eye diseases and conditions with a non-invasive, cost-effective treatment. We have an extensive global patent portfolio, comprising intellectual property ...
Manufactured by:Cingulate based inKansas City, KANSAS (USA)
Cingulate is developing ADHD medications capable of achieving precise once-daily dosing using a novel erosion based controlled release technology that provides unrivaled control of drug release. ...